Sort
261,768 grants matching “gene therapy”
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
$932,391Haian Fu · Emory University · U01 · FY2021 · CA
Illuminating the APOE Locus with Long-Read Sequencing and Targeted Genomics
$932,379Michael D Greicius · Stanford University · R35 · FY2022 · AG
Using gene expression profiles to elucidate mechanisms of melanoma progression
$932,378Ashani Weeraratna · Aging · Z01 · FY2007 · AG
NHLBI GTRP Lentivirus Vector Production Core Laboratory
$932,290Kenneth Cornetta · Indiana University Indianapolis · N01 · FY2011 · HL
Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy
$932,268Daniel Rotroff · Cleveland Clinic Lerner Com-Cwru · R33 · FY2024 · NS
Genetic modifiers of Duchenne Muscular Dystrophy
$932,236Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · NS
Reservoir depletion and anti-retroviral therapy for infant functional cure
$932,148Dennis J Hartigan-O'Connor · University Of California At Davis · R01 · FY2016 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing
$932,056Katharine June Bar · University Of Pennsylvania · R01 · FY2024 · MH
Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni
$932,044David E Kleiner · Clinical Sciences · Z01 · FY2007 · CA
Next Generation Immunotherapies for Pediatric Cancers
$932,006Crystal Mackall · Stanford University · R35 · FY2025 · CA
A New Target for Chromatin Remodeler Defects in Cancer
$931,976Cheryl L Walker · Baylor College Of Medicine · R35 · FY2023 · CA
Next Generation Immunotherapies for Pediatric Cancers
$931,841Crystal Mackall · Stanford University · R35 · FY2024 · CA
Mechanisms of Bile Secretion and Cholestasis
$931,545James Lorenzen Boyer · Yale University · R37 · FY2009 · DK
Leber Hereditary Optic Neuropathy: Gene Therapy Trial
$931,528John R Guy · University Of Miami School Of Medicine · R24 · FY2012 · EY
Implications of Genetic Diversity in Muscular Dystrophy
$931,491Dwi Utami Kemaladewi · University Of Pittsburgh At Pittsburgh · DP2 · FY2024 · AR
Cost-effectiveness of preventing HIV complications
$931,350Kenneth Alan Freedberg · Massachusetts General Hospital · R37 · FY2012 · AI
Therapeutic Targeting of Human AML Stem Cells
$931,335Craig T. Jordan · University Of Colorado Denver · R35 · FY2021 · CA
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$931,259Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Molecular pathways and targeted therapies in human leukemia
$931,200Adolfo A. Ferrando · Columbia University Health Sciences · R35 · FY2019 · CA
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
$931,200Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2019 · CA
Mechanisms governing metastatic dormancy and reactivation
$931,198Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · CA
Collaborative Research: Spatiotemporal Dynamics of Synthetic Microbial Consortia
$931,106Matthew R Bennett · William Marsh Rice University · · FY2017 · MPS
Role of the Epitranscriptome in Cancer
$931,087Richard I. Gregory · Boston Children'S Hospital · R35 · FY2019 · CA
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
$931,087M. Celeste Simon · University Of Pennsylvania · R35 · FY2019 · CA
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus
$931,045Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AI